Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
Medical marijuana: clearing away the smoke.
Transverse myelitis -- a review of the presentation, diagnosis, and initial management.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants.
ISMRM Workshop on Multiple Sclerosis as a Whole-Brain Disease
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
"Tell me what you want, what you really really want….": asking people with multiple sclerosis about enhancing their participation in physical activity.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Genmab collaborator GSK starts new ofatumumab Phase III study in rare skin disorder
Immunology 2012
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO)
Rituximab: Don't Count It Out as MS Treatment
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
[The Sjögren's syndrome and multiple sclerosis: similarity and differences.]
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.

Pages